Previous studies have shown that decreased GSN expression enhanced mesenchymal marker expression to promote cell migration, invasion, and metastasis in several types of cancers such as breast cancer, glioblastoma, and gastric cancer [29–31]. This evidence concerns the gene GSN and breast carcinoma.